Skip to content

Christopher Simon Hourigan, MD DPHIL

NPI 1124222468ActiveIndividual· Internal Medicine, Medical Oncology· Baltimore, MD

Internal Medicine, Medical Oncology (MD DPHIL) in Baltimore, Maryland, licensed in MD, with an NPI issued in June 2007. Astellas Pharma Global Development was the largest of 6 companies reporting payments in 2025, $10,614 in all, mostly consulting fees.

Overview

NPI1124222468
StatusActive
Entity typeIndividual
CredentialMD DPHIL
Sole proprietorNo
NPI issuedJun 12, 2007
Last updated in NPPESJan 12, 2024
Certified by providerJan 12, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Medical Oncology Primary207RX0202XD70925MD

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$10,614 · 7 payments from 6 companies

Top paying companies in 2025

What the 2025 payments were for

  • Consulting Fee$9,557 · 4 payments
  • Travel and Lodging$705.00 · 1 payment
  • Food and Beverage$351.89 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Medical Oncology providers in Baltimore

All Internal Medicine, Medical Oncology providers in Maryland →